Siccing a Virus on the Deadliest Cancers
The February 4th edition of BusinessWeek magazine includes a feature on Oncolytics Biotech, Inc. and the NCI ovarian trials called: Siccing a Virus on the Deadliest Cancers.
I think a mention in such a high profile magazine speaks to the importance of these trials and the investigation of Reolysin with ovarian cancer.
Read the article here.
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment